Bausch Health Companies Inc (BHC)

11.28
+1.83(+19.37%)
  • Volume:
    1,640,856
  • Bid/Ask:
    11.28/11.30
  • Day's Range:
    9.72 - 11.29
  • Type:Equity
  • Market:Canada
  • ISIN:CA0717341071
  • CUSIP:071734107

BHC Overview

Prev. Close
9.45
Day's Range
9.72-11.29
Revenue
10.84B
Open
9.95
52 wk Range
8.91-37.53
EPS
-1.48
Volume
1,640,856
Market Cap
4.06B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
904,832
P/E Ratio
-
Beta
1.73
1-Year Change
-73.64%
Shares Outstanding
361,479,708
Next Earnings Date
Aug 09, 2022
What is your sentiment on Bausch Health?
or
Market is currently closed. Voting is open during market hours.

Bausch Health Companies Inc Analysis

Bausch Health Companies Inc Company Profile

Bausch Health Companies Inc Company Profile

Employees
19600

Bausch Health Companies Inc. is a specialty pharmaceutical and medical device company. The Company develops, manufactures, and markets, primarily in the therapeutic areas of eye health, gastroenterology (GI), and dermatology, a range of branded, generic and branded generic pharmaceuticals, over the counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices) which are marketed directly or indirectly in approximately 100 countries. The Company operates through five segments: Bausch + Lomb, Salix, International, Solta Medical, and Diversified Products. The Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, Consumer, Surgical, and Ophthalmic Pharmaceuticals products. The Salix segment consists of sales in the United States of gastrointestinal (GI) products. The Solta Medical segment consists of global sales of Solta aesthetic medical devices.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuySellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Sell
  • bullish
    0
    • will look at this again at around $25, bearish till then
      0
      • sorry...who wrote the next comment.
        1
        • sing it! dreaming..... only dreaming. at what point do analyst get banned for 'fake' analysis?
          0
          • I do not trust analyst target. Last earnings did not meet analyst expectations. May be long term will reach target 90.00. I bought at 29.00 and sold at 35.00. I follow the chart and will buy again below 30.00.
            4
            • Analyst target for VRX is $90 I am in with 50 shares at $36 hoping analyst to be right this time about $90 target So should I be long on this stock ? Please share your comments
              0
              • Stay AWAY!!!!! Dangerous. Clinton will hit on Pharma constraints tonight. With 36 you will be ok in the long run, 6% as of now and have a feeling that 4% more is on the way
                0
              • Jeremiah Cox . re: "have a feeling", never be emotional about the markets.......it'd hurt you
                0